Press Releases Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
8.46 ^USD	-5.47%		-16.69%	+213.33%

04-11	Sector Update: Health Care Stocks Softer Late Afternoon	MT
04-11	Top Midday Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm	04-15	PR
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders	04-11	BU
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement	04-11	GL
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives	20/07/23	GL
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives	20/07/23	AQ
Eliem Therapeutics : Corporate Presentation – May 2023	11/05/23	PU
ELIEM THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	11/05/23	AQ
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights	11/05/23	GL
ELIEM THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	16/03/23	AQ
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	06/03/23	AQ
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights	06/03/23	GL
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights	06/03/23	GL
ELIEM THERAPEUTICS, INC. : Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	14/02/23	AQ
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition	09/02/23	GL
ELIEM THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	24/01/23	AQ
ELIEM THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	20/12/22	AQ
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference	30/11/22	GL
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Results and Operations (form 10-Q)	14/11/22	AQ
ELIEM THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/11/22	AQ
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights	14/11/22	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Press Releases

Filters